Astrana Health Inc. (NASDAQ: ASTH) is capturing the attention of investors with its remarkable revenue growth and substantial upside potential. Founded in 1994, the Alhambra, California-based company, formerly known as..
Alphatec Holdings, Inc. (NASDAQ: ATEC), a pioneering force in the healthcare sector, is capturing investor attention with its strong potential for growth. Specializing in medical devices, this Carlsbad, California-based company..
MannKind Corporation (NASDAQ: MNKD), a pioneering biopharmaceutical company, is becoming a focal point for investors seeking promising opportunities in the healthcare sector. With its dedication to developing innovative therapies for..
Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a biopharmaceutical company focused on innovative peptide therapeutics, has captured the attention of investors with its promising pipeline and strong analyst endorsements. Specializing in treatments..
Ocular Therapeutix, Inc. (NASDAQ: OCUL) has caught the eye of investors with its promising potential upside of 47.42%, according to recent analyst ratings. As a biopharmaceutical company focused on innovative..
AdaptHealth Corp. (NASDAQ: AHCO), a key player in the medical devices industry, presents a compelling investment opportunity with a projected upside of over 41%. Specializing in home medical equipment and..
Celldex Therapeutics, Inc. (NASDAQ: CLDX) stands at the forefront of the biotechnology sector, capturing investor attention with its cutting-edge research and promising drug candidates. As a biopharmaceutical company, Celldex is..
Mesoblast Limited (NASDAQ: MESO), an innovative leader in regenerative medicine, is capturing investor attention with a striking potential upside of 93.26%. Specializing in cutting-edge biotechnology, Mesoblast harnesses the power of..
Opko Health, Inc. (NASDAQ: OPK) operates at the intersection of diagnostics and pharmaceuticals, delivering a diverse range of healthcare solutions across the United States and internationally. With a market capitalization..
Apogee Therapeutics, Inc. (NASDAQ: APGE), a burgeoning player in the biotechnology sector, has quickly attracted investor attention due to its strategic focus on developing novel biologics targeting a range of..
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), a prominent player in the healthcare sector, is capturing investor attention with its promising potential upside of 33.73%. Specializing in both branded and generic pharmaceutical..
Premier, Inc. (NASDAQ: PINC), a key player in the healthcare sector, primarily operates within the health information services industry. The company, headquartered in Charlotte, North Carolina, has established itself as..
As the healthcare sector continues to evolve, 10x Genomics, Inc. (NASDAQ: TXG) stands out with its cutting-edge life science technology aimed at revolutionizing the analysis of biological systems. Despite a..
Integra LifeSciences Holdings Corporation (NASDAQ: IART) operates at the intersection of innovation and healthcare, providing a wide array of medical devices aimed at improving surgical outcomes and patient care. With..
Edgewise Therapeutics, Inc. (NASDAQ: EWTX) has emerged as a compelling player in the biotechnology sector, particularly for investors seeking exposure to innovative treatments for muscle disorders. With a market capitalization..
National HealthCare Corporation (NHC) stands as a stalwart in the healthcare sector, offering an array of medical care services that cater to a diverse range of needs, from skilled nursing..
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is drawing considerable attention in the healthcare sector, particularly among investors seeking opportunities in the drug manufacturing space. Specializing in both specialty and generic pharmaceuticals,..
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH), a prominent player in the biotechnology sector, is garnering attention from investors, particularly with an eye-catching 6.29% potential upside based on the average target price..
Veracyte, Inc. (NASDAQ: VCYT) stands as a notable player in the healthcare diagnostics and research industry, offering a suite of genomic tests designed to improve cancer diagnosis. With a market..
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) stands out in the biotechnology sector with its focus on pioneering treatments for rare genetic diseases through advancements in cellular metabolism. With a market capitalization..
